gets sensex krishna actor clarity clinical work drug company reddy sc ysrcp cost told acquires prabhakar sabha join consolidated sales official vaccine attack post revenue drdos produce human launches effective

Articles for Dr Reddys

Dr Reddys Laboratories Q2 Results Live: Profit Falls by 15.28% YoY
1 month, 2 weeks ago

Dr Reddys Laboratories Q2 Results Live: Profit Falls by 15.28% YoY

Live Mint  

Dr Reddys Laboratories Q2 Results Live : Dr Reddys Laboratories announced its Q2 results on November 5, 2024, revealing a mixed performance. In terms of market performance, Dr Reddys Laboratories has delivered a -0.2% return over the last week, a 1.65% return over the past six months, and a 9.71% return year-to-date. As of November 6, 2024, analysts remain cautious …

Laboratories Reddys Q2 Results Live Dr Dr Reddys Laboratories
Top Gainers and Losers today on 31 January, 2024: Dr Reddys Laboratories, Eicher Motors, Larsen & Toubro, Titan Company among most active stocks; Check full list here
10 months, 3 weeks ago

Top Gainers and Losers today on 31 January, 2024: Dr Reddys Laboratories, Eicher Motors, Larsen & Toubro, Titan Company among most active stocks; Check full list here

Live Mint  

The Nifty closed at 21522.1, up by 0.95% on the trading day. When looking at the returns of the Nifty 50 over different time periods, it has shown the following performance: - In the last 1 week, it has given a return of 1.28%. The top gainers in the Nifty index were Dr Reddys Laboratories, Eicher Motors, Sun Pharmaceutical Industries, …

India Nifty Eicher Motors Tata Motors Motors Gainers Top Gainers
Top Gainers and Losers today on 24 January, 2024: Hindalco Industries, Dr Reddys Laboratories, ICICI Bank, Axis Bank among most active stocks; Check full list here
10 months, 4 weeks ago

Top Gainers and Losers today on 24 January, 2024: Hindalco Industries, Dr Reddys Laboratories, ICICI Bank, Axis Bank among most active stocks; Check full list here

Live Mint  

The Nifty closed at 21,238.8, up by 1.01%. Similarly, small cap stocks outperformed the Nifty 50, with the Nifty Small Cap 100 ending at 15,073.05, up by 259.0 points or 1.72%. The Nifty 50 has shown the following returns: - In the last 1 week: -0.54% - In the last 1 month: 0.07% - In the last 3 months: 12.21% …

India Bank Nifty 50 Icici Bank Tata Industries Hcl Technologies
Dr Reddy's Dips 7% Even as Q4 Net Profit Jumps 10-Fold; Should you Buy, Sell or Hold?
1 year, 7 months ago

Dr Reddy's Dips 7% Even as Q4 Net Profit Jumps 10-Fold; Should you Buy, Sell or Hold?

News 18  

Shares of Dr Reddy’s Laboratories slipped 7 per cent in early trade on May 11, a day after the company posted its Q4 results. The drugmaker’s net profit for the quarter jumped 10-fold to Rs 959.2 crore from Rs 87.5 crore in the same period last year but still lagged the Street’s estimate of Rs 1,093.6 crore. “Dr Reddys’ reported …

Crore Cent Eps Yes Securities Grevlimid Dr Reddys
Why Dr Reddy's and Sun Pharma are recalling certain products from US market
2 years ago

Why Dr Reddy's and Sun Pharma are recalling certain products from US market

Hindustan Times  

Drug majors Dr Reddy's Laboratories and Sun Pharma are recalling different products in the US market for manufacturing issues, according to the US Food and Drug Administration. Representative Image As per the enforcement report by the US health regulator, the US-based arm of Dr Reddy's Laboratories is recalling over 48,000 cartons of a drug used to treat sneezing, runny or …

Sun Pharma Dr Reddy Recalling Certain Usfda Dr
Dr Reddy’s plans ’business continuity’ in Russia
2 years, 9 months ago

Dr Reddy’s plans ’business continuity’ in Russia

Live Mint  

Indian pharmaceutical major Dr. Reddy's Laboratories Ltd said on Wednesday it was focused on employee safety and business continuity in and around Russia, despite many Western companies pulling out from Russia in recent days. No Indian company has publicly withdrawn from Russia and New Delhi has declined to condemn Moscow's invasion of Ukraine, despite pressure from the United States to …

India Russia Dr Reddy Business Continuity
Mankind Pharma to Launch Cheapest Covid Antiviral Drug Molnupiravir at Rs 35 Per Capsule by Next Week
2 years, 11 months ago

Mankind Pharma to Launch Cheapest Covid Antiviral Drug Molnupiravir at Rs 35 Per Capsule by Next Week

News 18  

Mankind Pharma’s chairman has said the company’s will launch the cheapest Molnupiravir, the Covid-19 antiviral drug, at Rs 35 per capsule, the Economic Times said in a report. Molnupiravir, developed by MSD and Ridgeback Biotherapeutics, has been approved by the UK Medicines and Healthcare products Regulatory Agency and the US Food and Drug Administration for the treatment of mild-to-moderate Covid-19 …

Pharma Covid Mankind Pharma Cipla Capsule Launch Molnupiravir
India to Begin Testing Russia’s Single-Shot Sputnik Light Shortly, 1st Tranche Sent for Quality Testing
3 years, 3 months ago

India to Begin Testing Russia’s Single-Shot Sputnik Light Shortly, 1st Tranche Sent for Quality Testing

News 18  

As India gears up to kick-start the bridging trial of Russia’s single-shot vaccine, Sputnik Light, the first tranche has been sent for quality and safety validation, News18.com has learnt. “While samples of Sputnik Light, manufactured by domestic pharma company Panacea Biotec, have already been sent for quality, safety checks at the Central Drugs Laboratory in Kasauli, the hospitals have also …

India Russia Trial Light Indian Reddy Sec
Kerala plans to sign agreement with RDIF to fill Sputnik V vaccine vials
3 years, 5 months ago

Kerala plans to sign agreement with RDIF to fill Sputnik V vaccine vials

Hindustan Times  

Kerala may soon enter a deal with the Russian Direct Investment Fund, the country’s sovereign wealth fund, to set up a unit for filling Sputnik V Covid-19 vaccine vials, news agency ANI reported. The RDIF has entered into a partnership with Dr Reddy’s Labs to market the first 250 million doses of Sputnik V in India. Kerala industries principal secretary …

India Kerala Vaccine Sputnik Rdif Sputnik V Sputnik V Vaccine
Sputnik V to offer booster shot to other manufacturers, adjusted to work against Delta variant
3 years, 6 months ago

Sputnik V to offer booster shot to other manufacturers, adjusted to work against Delta variant

India TV News  

Sputnik V will soon offer a booster shot, adjusted to work against the Delta variant of coronavirus to other vaccine manufacturers, the Russian vaccine maker announced on Thursday. Meanwhile, Dr Reddys Laboratories which has soft-launched Russias COVID-19 vaccine Sputnik V has expanded the pilot which is in the final leg to other cities such as Mumbai, Bangalore and New Delhi. …

Vaccine Sputnik Dr Reddy Dr Reddys Sputnik V
Dr Reddy's, RDIF commence clinical trials for Sputnik V COVID-19 vaccine in India
4 years ago

Dr Reddy's, RDIF commence clinical trials for Sputnik V COVID-19 vaccine in India

India TV News  

Dr Reddy's Laboratories and Russian Direct Investment Fund on Tuesday said they have commenced adaptive phase 2/3 clinical trials for the Sputnik V COVID-19 vaccine in India. Further, Dr Reddy's has partnered with the Biotechnology Industry Research Assistance Council, Department of Biotechnology for advisory support and to use BIRAC's clinical trial centres for the vaccine, it added. "We are working …

Trials Clinical Trials Vaccine Clinical Sputnik Dr Reddy India Dr
Coronavirus | First batch of Sputnik V vaccine to arrive in Kanpur medical college for Phase 2, 3 trials
4 years, 1 month ago

Coronavirus | First batch of Sputnik V vaccine to arrive in Kanpur medical college for Phase 2, 3 trials

The Hindu  

The first batch of Russia’s Sputnik V vaccine for COVID-19 is likely to reach Kanpur’s Ganesh Shankar Vidyarthi Medical College by next week wherein the vaccine’s Phase 2 and Phase 3 human clinical trials will be conducted. The decision to conduct the human clinical trials of the vaccine was taken after Dr Reddy’s Laboratories got approval from the Drugs Controller …

India Russia Trials Vaccine Dr Reddy Sputnik V Vaccine Volunteers V
Dr.Reddy’s to get BIRAC support for Sputnik V vaccine clinical trials
4 years, 1 month ago

Dr.Reddy’s to get BIRAC support for Sputnik V vaccine clinical trials

The Hindu  

Dr. Reddy’s Laboratories has announced a collaboration with Biotechnology Industry Research Assistance Council to receive advisory support for the clinical trials of Russia’s Sputnik V vaccine that the company plans to start soon in the country. DBT Secretary and BIRAC Chairperson Renu Swarup said the government is committed to fast track clinical development of COVID vaccine candidates and provide facilitation …

India Russia Clinical Trials Reddy Vaccine Clinical Sputnik
Coronavirus vaccine: Dr Reddy’s partners with BIRAC for trials of Sputnik V in India
4 years, 1 month ago

Coronavirus vaccine: Dr Reddy’s partners with BIRAC for trials of Sputnik V in India

Live Mint  

Announcing its partnership with the Biotechnology Industry Research Assistance Council, set up by the Department of Biotechnology, for advisory support on clinical trials of Russian coronavirus vaccine, Sputnik V, in India, Dr Reddy's Laboratories said, "The partnership will allow Dr Reddy's to identify and use some of BIRAC's clinical trial centres for the vaccine, which are funded under the National …

India Coronavirus Trial Trials Clinical Trials Reddy Russian
If everything goes as planned, COVID-19 vaccine will come by mid-2021: AIIMS doctor
4 years, 3 months ago

If everything goes as planned, COVID-19 vaccine will come by mid-2021: AIIMS doctor

India TV News  

Dr Sanjay Rai, head of the Community Medicine Department at AIIMS-Delhi on Friday said that there is a possibility of normalcy returning to India by mid-next year, with or without a coronavirus vaccine. Any vaccine will come by mid-next year, anywhere in the world, if everything goes as planned," Dr Sanjay Rai said. Meanwhile, the Russian Direct Investment Fund, Russias …

India Next Year Vaccine Sanjay Rai Dr Reddys Dr Sanjay Rai